Literature DB >> 33378238

PCSK9 (Proprotein Convertase Subtilisin/Kexin 9) Goes "DAMP".

Roy L Silverstein1.   

Abstract

Entities:  

Keywords:  CD36; Editorials; PCSK9; platelets; thrombosis

Mesh：

Substances：

Year:  2020        PMID： 33378238      PMCID： PMC8006907          DOI： 10.1161/CIRCULATIONAHA.120.051940

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  15 in total

1.  Platelet CD36 surface expression levels affect functional responses to oxidized LDL and are associated with inheritance of specific genetic polymorphisms.

Authors:  Arunima Ghosh; Gurunathan Murugesan; Kan Chen; Li Zhang; Qing Wang; Maria Febbraio; Rita Marie Anselmo; Kandice Marchant; John Barnard; Roy L Silverstein
Journal:  Blood       Date:  2011-04-08       Impact factor: 22.113

2.  Advanced glycation end products induce a prothrombotic phenotype in mice via interaction with platelet CD36.

Authors:  Weifei Zhu; Wei Li; Roy L Silverstein
Journal:  Blood       Date:  2012-03-19       Impact factor: 22.113

3.  Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9.

Authors:  Jonathan Cohen; Alexander Pertsemlidis; Ingrid K Kotowski; Randall Graham; Christine Kim Garcia; Helen H Hobbs
Journal:  Nat Genet       Date:  2005-01-16       Impact factor: 38.330

Review 4.  PCSK9: From Basic Science Discoveries to Clinical Trials.

Authors:  Michael D Shapiro; Hagai Tavori; Sergio Fazio
Journal:  Circ Res       Date:  2018-05-11       Impact factor: 17.367

5.  Circulating Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Predicts Future Risk of Cardiovascular Events Independently of Established Risk Factors.

Authors:  Karin Leander; Anders Mälarstig; Ferdinand M Van't Hooft; Craig Hyde; Mai-Lis Hellénius; Jason S Troutt; Robert J Konrad; John Öhrvik; Anders Hamsten; Ulf de Faire
Journal:  Circulation       Date:  2016-02-19       Impact factor: 29.690

6.  PCSK9 (Proprotein Convertase Subtilisin/Kexin 9) Enhances Platelet Activation, Thrombosis, and Myocardial Infarct Expansion by Binding to Platelet CD36.

Authors:  Zhiyong Qi; Liang Hu; Jianjun Zhang; Wenlong Yang; Xin Liu; Daile Jia; Zhifeng Yao; Lin Chang; Guanxing Pan; Haoxuan Zhong; Xinping Luo; Kang Yao; Aijun Sun; Juying Qian; Zhongren Ding; Junbo Ge
Journal:  Circulation       Date:  2020-09-29       Impact factor: 29.690

7.  A specific CD36-dependent signaling pathway is required for platelet activation by oxidized low-density lipoprotein.

Authors:  Kan Chen; Maria Febbraio; Wei Li; Roy L Silverstein
Journal:  Circ Res       Date:  2008-05-22       Impact factor: 17.367

Review 8.  CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior.

Authors:  Roy L Silverstein; Maria Febbraio
Journal:  Sci Signal       Date:  2009-05-26       Impact factor: 8.192

Review 9.  CD36 signaling in vascular redox stress.

Authors:  Moua Yang; Roy L Silverstein
Journal:  Free Radic Biol Med       Date:  2019-02-27       Impact factor: 8.101

10.  NLRP3 inflammasome via IL-1β regulates PCSK9 secretion.

Authors:  Zufeng Ding; Xianwei Wang; Shijie Liu; Sichang Zhou; Rajshekhar A Kore; Shengyu Mu; Xiaoyan Deng; Yubo Fan; Jawahar L Mehta
Journal:  Theranostics       Date:  2020-05-30       Impact factor: 11.600
View more
  2 in total

Review 1.  PCSK9 and Other Metabolic Targets to Counteract Ischemia/Reperfusion Injury in Acute Myocardial Infarction and Visceral Vascular Surgery.

Authors:  Silvia Ortona; Chiara Barisione; Pier Francesco Ferrari; Domenico Palombo; Giovanni Pratesi
Journal:  J Clin Med       Date:  2022-06-23       Impact factor: 4.964

Review 2.  Inflammation and atherosclerosis: signaling pathways and therapeutic intervention.

Authors:  Peng Kong; Zi-Yang Cui; Xiao-Fu Huang; Dan-Dan Zhang; Rui-Juan Guo; Mei Han
Journal:  Signal Transduct Target Ther       Date:  2022-04-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.